We further validated the expression of MAP3K14 using the UALCAN database and GEO datasets of paired HCC samples, which showed significantly higher expression levels of MAP3K14 in tumor tissues compared to adjacent non-tumor tissues. Here, MAP3K14 is linked to hepatocellular carcinoma.